Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMC 2916572)

Published in J Clin Microbiol on June 16, 2010

Authors

Li Xiao1, John I Glass, Vanya Paralanov, Shibu Yooseph, Gail H Cassell, Lynn B Duffy, Ken B Waites

Author Affiliations

1: Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35249, USA.

Articles citing this

Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res (2011) 1.60

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains. BMC Microbiol (2012) 1.21

Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn (2012) 1.14

Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes. J Clin Microbiol (2011) 1.07

Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States. Antimicrob Agents Chemother (2012) 1.05

Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia. Pediatr Infect Dis J (2011) 1.05

Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. Am J Obstet Gynecol (2012) 1.00

Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. Int J Bacteriol (2013) 0.93

Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia. J Clin Pharmacol (2010) 0.92

Development of a multilocus sequence typing scheme for Ureaplasma. Eur J Clin Microbiol Infect Dis (2013) 0.89

Serological investigation of Ureaplasma urealyticum in Korean preterm infants. Korean J Pediatr (2013) 0.85

Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. Antimicrob Agents Chemother (2013) 0.84

Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex Transm Infect (2016) 0.83

Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates. Pediatr Infect Dis J (2013) 0.81

Correlation between Ureaplasma subgroup 2 and genitourinary tract disease outcomes revealed by an expanded multilocus sequence typing (eMLST) scheme. PLoS One (2014) 0.79

Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. Antimicrob Agents Chemother (2014) 0.78

Comparison of the new Mycofast Revolution assay with a molecular assay for the detection of genital mycoplasmas from clinical specimens. BMC Infect Dis (2013) 0.78

High-resolution melt PCR analysis for genotyping of Ureaplasma parvum isolates directly from clinical samples. J Clin Microbiol (2013) 0.78

Genotypic characterization of ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis. J Clin Microbiol (2011) 0.77

Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update. Clin Perinatol (2015) 0.76

Comparison between culture and a multiplex quantitative real-time polymerase chain reaction assay detecting Ureaplasma urealyticum and U. parvum. PLoS One (2014) 0.75

A Case of Rectal Ureaplasma Infection and Implications for Testing in Young Men Who Have Sex with Men: The P18 Cohort Study. LGBT Health (2016) 0.75

Viral Respiratory Infections in Preterm Infants during and after Hospitalization. J Pediatr (2016) 0.75

The Human Ureaplasma Species as Causative Agents of Chorioamnionitis. Clin Microbiol Rev (2016) 0.75

Beyond the uterine environment: Nonhuman primate model to investigate maternal-fetal and neonatal outcomes following chronic intrauterine infection. Pediatr Res (2017) 0.75

Articles cited by this

The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am J Syph Gonorrhea Vener Dis (1954) 5.45

Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev (2005) 3.20

Direct and indirect immunofluorescence of unfixed and fixed Mycoplasma colonies. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 3.18

Serological typing of Ureaplasma urealyticum isolates from urethritis patients by an agar growth inhibition method. J Clin Microbiol (1978) 2.88

Modifications of the growth inhibition test and its application to human T-mycoplasmas. Appl Microbiol (1973) 2.68

Ureaplasma urealyticum urease genes; use of a UGA tryptophan codon. Mol Microbiol (1990) 2.13

Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol (2002) 1.97

Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol (2000) 1.94

Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns. Clin Infect Dis (1993) 1.88

Modified metabolic inhibition test for serotyping strains of Ureaplasma urealyticum (T-strain Mycoplasma). J Clin Microbiol (1979) 1.82

Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans. J Clin Microbiol (1982) 1.81

Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes. Infect Immun (1990) 1.65

Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol (1993) 1.55

Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis. Sex Transm Dis (2004) 1.54

Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates. Infect Immun (1992) 1.50

Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene. J Clin Microbiol (1994) 1.42

Modified colony indirect epifluorescence test for serotyping Ureaplasma urealyticum and an adaptation to detect common antigenic specificity. J Clin Microbiol (1981) 1.42

The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol (2003) 1.38

Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR. Mol Cell Probes (2005) 1.30

Polymerase chain reaction versus culture for detection of Ureaplasma urealyticum and Mycoplasma hominis in the urogenital tract of adults and the respiratory tract of newborns. Eur J Clin Microbiol Infect Dis (1996) 1.29

Serotyping of Ureaplasma urealyticum by immunoperoxidase assay. J Clin Microbiol (1981) 1.24

Comparative analysis and serovar-specific identification of multiple-banded antigen genes of Ureaplasma urealyticum biovar 1. J Clin Microbiol (1999) 1.23

Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol (2005) 1.10

Comparison of polymerase chain reaction assay with culture for detection of genital mycoplasmas in perinatal infections. Eur J Clin Microbiol Infect Dis (1998) 1.09

Detection of Ureaplasma urealyticum by PCR and biovar determination by liquid hybridization. J Clin Microbiol (1998) 1.09

Comparison of PCR, nested PCR, and random amplified polymorphic DNA PCR for detection and typing of Ureaplasma urealyticum in specimens from pregnant women. J Clin Microbiol (1998) 1.08

Comparison of PCR with culture for detection of Ureaplasma urealyticum in clinical samples from patients with urogenital infections. J Clin Microbiol (1994) 1.03

Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum. J Microbiol Methods (2005) 1.03

Alternate phase variation in expression of two major surface membrane proteins (MBA and UU376) of Ureaplasma parvum serovar 3. FEMS Microbiol Lett (2009) 1.00

Serological characterisation of Ureaplasma urealyticum strains by enzyme-linked immunosorbent assay (ELISA). J Clin Pathol (1982) 0.99

Quantitative detection of Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in urine specimens from men with and without urethritis by real-time polymerase chain reaction. Sex Transm Dis (2007) 0.98

Rapid detection and biovar differentiation of Ureaplasma urealyticum in clinical specimens by PCR. J Formos Med Assoc (1995) 0.95

Molecular genotyping of human Ureaplasma species based on multiple-banded antigen (MBA) gene sequences. Int J Syst Evol Microbiol (2000) 0.95

Real-time TaqMan polymerase chain reaction assays for quantitative detection and differentiation of Ureaplasma urealyticum and Ureaplasma parvum. Diagn Microbiol Infect Dis (2006) 0.95

Differentiation of two biovars of Ureaplasma urealyticum based on the 16S-23S rRNA intergenic spacer region. J Clin Microbiol (1999) 0.92

The phylogeny of Ureaplasma urealyticum based on the mba gene fragment. Int J Syst Bacteriol (1998) 0.91

Polymerase chain reaction-based subtyping of ureaplasma parvum and ureaplasma urealyticum in first-pass urine samples from men with or without urethritis. Sex Transm Dis (2005) 0.90

Two multiplex real-time TaqMan polymerase chain reaction systems for simultaneous detecting and serotyping of Ureaplasma parvum. Diagn Microbiol Infect Dis (2007) 0.89

Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates. Clin Diagn Lab Immunol (2000) 0.89

Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCR-single-strand conformation polymorphism analysis. J Clin Microbiol (2001) 0.84

Articles by these authors

The Sorcerer II Global Ocean Sampling expedition: northwest Atlantic through eastern tropical Pacific. PLoS Biol (2007) 23.58

Creation of a bacterial cell controlled by a chemically synthesized genome. Science (2010) 13.45

Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science (2008) 10.90

A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59

Essential genes of a minimal bacterium. Proc Natl Acad Sci U S A (2006) 6.31

Whole-genome shotgun assembly and comparison of human genome assemblies. Proc Natl Acad Sci U S A (2004) 6.08

A whole-cell computational model predicts phenotype from genotype. Cell (2012) 5.98

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics (2004) 4.74

The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med (2015) 4.49

Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother (2003) 4.29

Genome transplantation in bacteria: changing one species to another. Science (2007) 3.95

Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J Bacteriol (2006) 3.40

Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev (2008) 3.20

Analyses of the microbial diversity across the human microbiome. PLoS One (2012) 2.98

Genomic insights to SAR86, an abundant and uncultivated marine bacterial lineage. ISME J (2011) 2.97

The Sorcerer II Global Ocean Sampling Expedition: metagenomic characterization of viruses within aquatic microbial samples. PLoS One (2008) 2.91

Creating bacterial strains from genomes that have been cloned and engineered in yeast. Science (2009) 2.74

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis (2007) 2.44

A genome-scale metabolic reconstruction of Mycoplasma genitalium, iPS189. PLoS Comput Biol (2009) 2.02

Viral photosynthetic reaction center genes and transcripts in the marine environment. ISME J (2007) 1.84

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest (2002) 1.84

The JCVI standard operating procedure for annotating prokaryotic metagenomic shotgun sequencing data. Stand Genomic Sci (2010) 1.82

Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies. J Clin Microbiol (2005) 1.79

Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PLoS One (2011) 1.79

METAREP: JCVI metagenomics reports--an open source tool for high-performance comparative metagenomics. Bioinformatics (2010) 1.72

Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol (2006) 1.71

Candidate phylum TM6 genome recovered from a hospital sink biofilm provides genomic insights into this uncultivated phylum. Proc Natl Acad Sci U S A (2013) 1.69

Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J (2009) 1.62

Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res (2011) 1.60

Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101. Antimicrob Agents Chemother (2009) 1.59

Stalking the fourth domain in metagenomic data: searching for, discovering, and interpreting novel, deep branches in marker gene phylogenetic trees. PLoS One (2011) 1.56

In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother (2003) 1.53

Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med (2013) 1.47

A case study for large-scale human microbiome analysis using JCVI's metagenomics reports (METAREP). PLoS One (2012) 1.44

Evolution of allostery in the cyclic nucleotide binding module. Genome Biol (2007) 1.44

Cloning whole bacterial genomes in yeast. Nucleic Acids Res (2010) 1.43

Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci (2009) 1.37

Macrolide-Resistant Mycoplasma pneumoniae, United States. Emerg Infect Dis (2015) 1.36

Essence of life: essential genes of minimal genomes. Trends Cell Biol (2011) 1.34

Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J (2005) 1.33

Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int J Antimicrob Agents (2011) 1.30

Haplotyping as perfect phylogeny: a direct approach. J Comput Biol (2003) 1.29

Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae. Emerg Infect Dis (2005) 1.26

Metagenomic exploration of viruses throughout the Indian Ocean. PLoS One (2012) 1.23

Going deeper: metagenome of a hadopelagic microbial community. PLoS One (2011) 1.23

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Antimicrob Agents Chemother (2006) 1.23

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains. BMC Microbiol (2012) 1.21

Ureaplasma infection and neonatal lung disease. Semin Perinatol (2007) 1.18

ThurGood: evaluating assembly-to-assembly mapping. J Comput Biol (2004) 1.16

Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn (2012) 1.14

An in vitro biofilm model system maintaining a highly reproducible species and metabolic diversity approaching that of the human oral microbiome. Microbiome (2013) 1.13

Bacillus cereus bacteremia in a preterm neonate. J Clin Microbiol (2003) 1.13

Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol (2005) 1.10

Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes. J Clin Microbiol (2011) 1.07

Sore Throat: Avoid Overcomplicating the Uncomplicated. Ann Intern Med (2015) 1.07

Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia. J Clin Microbiol (2004) 1.06

ANDES: Statistical tools for the ANalyses of DEep Sequencing. BMC Res Notes (2010) 1.05

Lung pathology in premature infants with Ureaplasma urealyticum infection. Pediatr Dev Pathol (2002) 1.05

Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States. Antimicrob Agents Chemother (2012) 1.05

Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia. Pediatr Infect Dis J (2011) 1.05

Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res (2003) 1.04

Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system. J Interferon Cytokine Res (2003) 1.02

Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms. Microbiology (2013) 1.00

In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob Agents Chemother (2003) 1.00

Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. Am J Obstet Gynecol (2012) 1.00

Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America. J Clin Microbiol (2003) 1.00

USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. J Clin Microbiol (2007) 1.00

Direct transfer of whole genomes from bacteria to yeast. Nat Methods (2013) 0.99

Assembly of large, high G+C bacterial DNA fragments in yeast. ACS Synth Biol (2012) 0.98

Mycoplasma pneumoniae Infections in Childhood. Pediatr Infect Dis J (2014) 0.98

Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. J Clin Microbiol (2006) 0.97

Sequence analysis of a complete 1.66 Mb Prochlorococcus marinus MED4 genome cloned in yeast. Nucleic Acids Res (2012) 0.97

Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J Clin Microbiol (2012) 0.97

A versatile palindromic amphipathic repeat coding sequence horizontally distributed among diverse bacterial and eucaryotic microbes. BMC Genomics (2010) 0.97

Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets. J Virol (2014) 0.96

Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother (2003) 0.96

A systems biology tour de force for a near-minimal bacterium. Mol Syst Biol (2009) 0.95

Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons. J Interferon Cytokine Res (2006) 0.94

Targeted chromosomal knockouts in Mycoplasma pneumoniae. Appl Environ Microbiol (2010) 0.94

New selectable marker for manipulating the simple genomes of Mycoplasma species. Antimicrob Agents Chemother (2009) 0.93